Earnings quality and audit warnings dominate the tape

Asian Hotels (West) has received an adverse audit opinion citing a massive working capital deficit. It is a dire signal. With no meaningful revenue and a mountain of liabilities, the company's status as a going concern is now in doubt.

CIAN Agro reported a massive jump in consolidated profit to ₹223 cr, yet auditors have flagged concerns over impairment assessments and liability write-backs. These accounting frictions suggest the quality of the earnings is far lower than the headline growth implies. The numbers are simply not clean.

Pace Digitek’s consolidated profit surged 88% to ₹105.9 cr, but the standalone business is showing clear signs of weakness. The group's performance is now entirely dependent on its battery storage subsidiary. Investors should look past the headline profit to the core business decline.

Sudarshan Chemical has set a target of €35 million in EBITDA for its Heubach acquisition this year. It is a concrete yardstick. The company must now prove it can turn a distressed asset into a profitable one to justify the acquisition's long-term viability.

Indian Metals & Ferro Alloys is investing ₹110 cr for a 26% stake in a 65 MW hybrid power project. This move secures captive energy for its power-intensive operations. It replaces a previously failed contract, stabilizing costs for the long term.

Fredun Pharmaceuticals posted a 60% jump in profit and announced a 2:1 bonus issue. While the auditor noted a procedural delay in dividend transfers, the board's decision to expand capital signals confidence in cash flow.

Sagarsoft’s cash reserves have plummeted to just ₹0.92 cr, down from over ₹11 cr last year. The cash is gone. With the company swinging to a loss and taking impairment charges on acquisitions, its inorganic growth strategy is failing.

Kerala Ayurveda has set an ambitious revenue target of ₹200 cr by FY27. Achieving this would require revenue equivalent to nearly three-quarters of its current market cap. Execution is the only metric that matters now.

Happiest Minds has reaffirmed its 12.5% growth target for FY27. While the guidance provides stability, the lack of quantified deal values for its new platform leaves investors without a clear catalyst for near-term upside.